A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2, 2010, Pages 374-380

  Camargo Jr , Carlos A ^a   Gurner, Deborah M ^b   Smithline, Howard A ^c   Chapela, Rocio ^d   Fabbri, Leonardo M ^e   Green, Stuart A ^b   Malice, Marie Pierre ^b   Legrand, Catherine ^b   Dass, S Balachandra ^b   Knorr, Barbara A ^b   Reiss, Theodore F ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

acute asthma; asthma exacerbation; FEV1; hospitalization; Intravenous montelukast; leukotriene receptor antagonist; randomized trial

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE; MONTELUKAST; PLACEBO; PREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ACETATES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ASTHMA; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; QUINOLINES; RESPIRATORY FUNCTION TESTS; YOUNG ADULT;

EID: 75849157844     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.11.015     Document Type: Article

References (29)

1. Tillie-Leblond I., Gosset P., and Tonnel A.B. Inflammatory events in severe acute asthma. Allergy 60 (2005) 23-29
2. Rodrigo G.J., Rodrigo C., and Hall J.B. Acute asthma in adults: a review. Chest 125 (2004) 1081-1102
3. Cairns C.B. Acute asthma exacerbations: phenotypes and management. Clin Chest Med 27 (2006) 99-108
4. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention-updated 2009. Available at: http://www.ginasthma.org. Accessed January 23, 2010.
5. McFadden E.R. Acute severe asthma. Am J Respir Crit Care Med 168 (2003) 740-759
6. Kuitert L.M., and Watson D. Antileukotrienes as adjunctive therapy in acute asthma. Drugs 67 (2007) 1665-1670
7. Bjermer L. Montelukast in the treatment of asthma as a systemic disease. Expert Rev Clin Immonol 1 (2005) 325-336
8. Nayak A. A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin Pharmacother 5 (2004) 679-686
9. Reiss T.F., Knorr B., Malmstrom K., Noonan G., and Lu S. Clinical efficacy of montelukast in adults and children. Clin Exp Allergy Rev 1 (2001) 264-273
10. Price D.B., Hernandez D., Magyar P., Fiterman J., Beeh K.M., James I.G., et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 58 (2003) 211-216
11. Dempsey O.J., Wilson A.M., Sims E.J., Mistry C., and Lipworth B.J. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids. Chest 117 (2000) 950-953
12. Laviolette M., Malmstrom K., Lu S., Chervinsky P., Pujet J.C., Peszek I., et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med 160 (1999) 1862-1868
13. Dockhorn R.J., Baumgartner R.A., Leff J.A., Noonan M., Vandormael K., Stricker W., et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 55 (2000) 260-265
14. Camargo Jr. C.A., Smithline H.A., Malice M.P., Green S.A., and Reiss T.F. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 167 (2003) 528-533
15. Green S.A., Malice M.P., Tanaka W., Tozzi C.A., and Reiss T.F. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax 59 (2004) 100-104
16. Berger W., De Chandt M.T., and Cairns C.B. Zileuton: clinical implications of 5-lipoxygenase inhibition in severe airway disease. Int J Clin Pract 61 (2007) 663-676
17. National Asthma Education and Prevention Program (NAEPP). Guidelines for the diagnosis and management of asthma. NHLBI Expert Panel report III. 2007; NIH publication no. 08-5846.
18. Weber E.J., Silverman R.A., Callaham M.L., Pollack C.V., Woodruff P.G., Clark S., et al. A prospective multicenter study of factors associated with hospital admission among adults with acute asthma. Am J Med 113 (2002) 371-378
19. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2002. NIH publication no. 02-3659.
20. Bauer P. Multiple testing in clinical trials. Stat Med 10 (1991) 871-890
21. Henry R.L. Outcome evaluation of early discharge after hospitalization for asthma. Curr Opin Allergy Clin Immunol 6 (2006) 172-174
22. Blanchard J.C., Haywood Y.C., and Scott C. Racial and ethnic disparities in health: an emergency medicine perspective. Acad Emerg Med 10 (2003) 1289-1293
23. Jackson P. The impact of health insurance status on emergency room services. J Health Soc Policy 14 (2001) 61-74
24. Markoff B.A., MacMillan J.F., and Kumra V. Discharge of the asthmatic patient. Clin Rev Allergy Immunol 20 (2001) 341-355
25. Stewart M., Werneke U., MacFaul R., Taylor-Meek J., Smith H.E., and Smith I.J. Medical and social factors associated with the admission and discharge of acutely ill children. Arch Dis Child 79 (1998) 219-224
26. Kleinman A., Eisenberg L., and Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 88 (1978) 251-258
27. Silverman R.A., Osborn H., Runge J., Gallagher E.J., Chiang W., Feldman J., et al. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest 122 (2002) 489-497
28. Raimondi A.C., Schottlender J., Lombardi D., and Molfino N.A. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest 112 (1997) 24-28
29. Bolliger C.T., and Perruchoud A.P. Acute severe asthma: emergency diagnostic and therapeutic measures. Schweiz Med Wochenschr 122 (1992) 1823-1830